Which pharmaceutical company was the first to implement a value-based pricing model for cancer drugs that offered refunds if patients didn't respond to treatment?

The pharmaceutical industry uses various pricing strategies to balance research investments, market competition, and patient accessibility. Some companies have made landmark decisions that shifted industry norms. This poll tests your knowledge about significant pricing strategy innovations in the medical product landscape that changed how medications are valued and distributed globally.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Novartis with its CAR-T therapy Kymriah
Merck with its immunotherapy Keytruda
Pfizer with its breast cancer drug Ibrance
Bristol-Myers Squibb with its immunotherapy Opdivo